Distinguished in Hairy Cell Leukemia (HCL)

Antonella Anastasia

Brescia, IT 
Distinguished in Hairy Cell Leukemia (HCL)
Brescia, IT 
OverviewLocationsClinical Research

Overview

Antonella Anastasia practices in Brescia, Italy. Ms. Anastasia is rated as a Distinguished expert by MediFind in the treatment of Hairy Cell Leukemia (HCL). Her top areas of expertise are Follicular Lymphoma, Hairy Cell Leukemia (HCL), Hodgkin Lymphoma, Splenectomy, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 38 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Hairy Cell Leukemia (HCL).

Gender
Female

Locations

Brescia, Italy
Other Locations
Turin, Italy
Milan, Italy
Latina, Italy
Bologna, Italy
Rozzano, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized Phase III Multicenter Trial Assessing Efficacy and Toxicity of a Combination of Rituximab and Lenalidomide (R2) vs Rituximab Alone as Maintenance After Chemoimmunotherapy With Rituximab-chemotherapy (R-CHT) for Relapsed/Refractory FL Patients Not Eligible for Autologous Transplantation (ASCT).
A Randomized Phase III Multicenter Trial Assessing Efficacy and Toxicity of a Combination of Rituximab and Lenalidomide (R2) vs Rituximab Alone as Maintenance After Chemoimmunotherapy With Rituximab-chemotherapy (R-CHT) for Relapsed/Refractory FL Patients Not Eligible for Autologous Transplantation (ASCT).
Enrollment Status: Active_not_recruiting
Publish Date: May 30, 2025
Intervention Type: Drug
Study Drugs: R2-MANT, R-MANT
Study Phase: Phase 3

38 Total Publications

Review of the Management of Relapsed/Refractory Follicular Lymphoma: An Italian Perspective.
Review of the Management of Relapsed/Refractory Follicular Lymphoma: An Italian Perspective.
Journal: Hematological oncology
Published: June 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Anastasia's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile